HX575: established biosimilarity in the treatment of renal anemia and 10 years of clinical experience

Frank Dellanna,1 David Goldsmith,2 Andriy Krendyukov,3 Andreas Seidl,4 Nadja Höbel,5 Christian Combe6,7 1MVZ Davita Rhein-Ruhr, Düsseldorf, Germany; 2Division of Nephrology, Guy’s and St Thomas’ Hospitals, London, UK; 3Hematology/Nephrology, Hexal AG, Holzkirchen, 4Technical Development Biosimilars,...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Dellanna F (Egilea), Goldsmith D (Egilea), Krendyukov A (Egilea), Seidl A (Egilea), Höbel N (Egilea), Combe C (Egilea)
Formatua: Liburua
Argitaratua: Dove Medical Press, 2017-12-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri